These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28446521)

  • 41. Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
    Franchi F; Rollini F; Aggarwal N; Hu J; Kureti M; Durairaj A; Duarte VE; Cho JR; Been L; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2016 Sep; 134(11):780-92. PubMed ID: 27559041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction.
    Mohammad MA; Andell P; Koul S; James S; Scherstén F; Götberg M; Erlinge D
    Platelets; 2017 Jun; 28(4):414-416. PubMed ID: 27885888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Negative Impact of ST-Segment Elevation Myocardial Infarction and Morphine Dose on Ticagrelor Uptake and Pharmacodynamics: A Population PK/PD Analysis of Pooled Individual Participant Data.
    Konecki C; Holm M; Djerada Z
    Clin Pharmacokinet; 2023 Jun; 62(6):905-920. PubMed ID: 37097605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with mild hepatic impairment.
    Butler K; Teng R
    J Clin Pharmacol; 2011 Jul; 51(7):978-87. PubMed ID: 20926753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study.
    Montalescot G; Lassen JF; Hamm CW; Lapostolle F; Silvain J; ten Berg JM; Cantor WJ; Goodman SG; Licour M; Tsatsaris A; van't Hof AW
    Am Heart J; 2013 Apr; 165(4):515-22. PubMed ID: 23537967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina. A pharmacokinetic/pharmacodynamic study.
    Niezgoda P; Sikora J; Barańska M; Sikora A; Buszko K; Siemińska E; Marszałł MP; Siller-Matula JM; Jilma B; Alexopoulos D; Fabiszak T; Kubica J
    Thromb Haemost; 2017 Apr; 117(4):718-726. PubMed ID: 28203684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.
    Rafique AM; Nayyar P; Wang TY; Mehran R; Baber U; Berger PB; Tobis J; Currier J; Dave RH; Henry TD
    JACC Cardiovasc Interv; 2016 May; 9(10):1036-46. PubMed ID: 27198684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prehospital ticagrelor in ST-segment elevation myocardial infarction.
    Montalescot G; van 't Hof AW; Lapostolle F; Silvain J; Lassen JF; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Goodman SG; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Stibbe O; Ecollan P; Heutz WM; Swahn E; Collet JP; Willems FF; Baradat C; Licour M; Tsatsaris A; Vicaut E; Hamm CW;
    N Engl J Med; 2014 Sep; 371(11):1016-27. PubMed ID: 25175921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ticagrelor overcomes high platelet reactivity in patients with acute myocardial infarction or coronary artery in-stent restenosis: a randomized controlled trial.
    Li P; Yang Y; Chen T; Liu Y; Cao A; Liu J; Wang Z; Zhao X; Qin Y; Ma L
    Sci Rep; 2015 Sep; 5():13789. PubMed ID: 26350388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lessons from platelet inhibition and patient outcomes.
    Held C
    Curr Opin Cardiol; 2012 Jul; 27(4):355-60. PubMed ID: 22565140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
    de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
    Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI.
    Alexopoulos D; Gkizas V; Patsilinakos S; Xanthopoulou I; Angelidis C; Anthopoulos P; Makris G; Perperis A; Karanikas S; Koutsogiannis N; Davlouros P; Deftereos S; Chiladakis J; Hahalis G
    J Am Coll Cardiol; 2013 Sep; 62(10):940-1. PubMed ID: 23747780
    [No Abstract]   [Full Text] [Related]  

  • 53. Differential impact of fentanyl and morphine doses on ticagrelor-induced platelet inhibition in ST-segment elevation myocardial infarction: a subgroup analysis from the PERSEUS randomized trial.
    Garin D; Degrauwe S; Carbone F; Musayeb Y; Lauriers N; Valgimigli M; Iglesias JF
    Front Cardiovasc Med; 2024; 11():1324641. PubMed ID: 38628315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects.
    Teng R; Mitchell P; Butler K
    Eur J Clin Pharmacol; 2013 Apr; 69(4):877-83. PubMed ID: 23093043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of diabetic patients hospitalized for acute coronary syndromes: a prospective multicenter registry.
    Ferlini M; Musumeci G; Demarchi A; Grieco N; Mafrici A; De Servi S; Rossini R; Sponzilli C; Bognetti P; Cardile A; Frattini S; Ielasi A; Russo A; Vecchiato C; Lettieri C; Visconti LO
    J Cardiovasc Med (Hagerstown); 2017 Aug; 18(8):572-579. PubMed ID: 28590305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. P2Y
    Guimarães LF; Généreux P; Silveira D; Pesaro AE; Falcão F; Barbosa BR; de Souza CF; Fonseca FA; Alves CM; Carvalho AC; Stone GW; Caixeta A
    Int J Cardiol; 2017 Mar; 230():204-208. PubMed ID: 28062136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of PEAR1 rs12041331 polymorphism and pharmacodynamics of ticagrelor in healthy Chinese volunteers.
    Li M; Hu Y; Wen Z; Li H; Hu X; Zhang Y; Zhang Z; Xiao J; Tang J; Chen X
    Xenobiotica; 2017 Dec; 47(12):1130-1138. PubMed ID: 27937053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
    Velders MA; Abtan J; Angiolillo DJ; Ardissino D; Harrington RA; Hellkamp A; Himmelmann A; Husted S; Katus HA; Meier B; Schulte PJ; Storey RF; Wallentin L; Gabriel Steg P; James SK;
    Heart; 2016 Apr; 102(8):617-25. PubMed ID: 26848185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized, Crossover Trial.
    Jeong HS; Hong SJ; Cho SA; Kim JH; Cho JY; Lee SH; Joo HJ; Park JH; Yu CW; Lim DS
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1646-1658. PubMed ID: 28838475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.